Cardiovascular disease does not arrive without warning — it builds silently over years, driven by risk factors that are entirely detectable long before symptoms appear. Most people who have a heart attack had elevated blood pressure, elevated cholesterol, or other measurable warning signs for years beforehand. The tests that could have identified those risks are straightforward, widely available, and take less than an hour to complete.
Getting ahead of heart disease before 50 is one of the most effective health investments you can make. This guide covers the specific tests that matter and why each one earns its place.
Why Heart Health Testing Before 50 Matters
The scale of cardiovascular disease in the UK makes a compelling case for testing well before symptoms appear.
The British Heart Foundation confirms that around 36,000 people under the age of 75 die from heart disease in the UK every year, and that at least 12 young people under the age of 35 die each week from an undiagnosed heart condition. Critically, around 70% of the UK’s cardiovascular burden is associated with modifiable risk factors — meaning the majority of cardiovascular disease is, in principle, preventable with early identification and appropriate intervention.
The problem is that the most important cardiovascular risk factors — high blood pressure, elevated cholesterol, and pre-diabetes — produce no symptoms. A person can carry a ten-year heart attack risk that warrants treatment while feeling entirely well. The only way to find out is to test.
Before 50 is the ideal time to establish a baseline, understand your numbers, and intervene while the window for lifestyle change and, where needed, medication is still wide open. The NHS Health Check begins at 40, but for many people its scope is insufficient — and for those under 40 with a family history or risk factors, there is no routine NHS entitlement at all.
Blood Pressure
High blood pressure — hypertension — is the single most important modifiable cardiovascular risk factor in the UK. It significantly increases the risk of heart attack, stroke, heart failure, and kidney disease, and it causes no symptoms until damage has already occurred.
Blood pressure is measured as two numbers: systolic (the pressure when the heart beats) over diastolic (the pressure between beats), expressed in mmHg. A normal reading for most adults is below 120/80 mmHg. A consistent reading of 140/90 mmHg or above indicates hypertension requiring clinical assessment and, in many cases, treatment.
The insidious nature of hypertension is that readings between 120/80 and 140/90 — sometimes called high-normal or stage 1 elevated blood pressure — carry meaningfully increased cardiovascular risk even before reaching the clinical threshold for a diagnosis. A single reading is a snapshot; regular monitoring over time reveals whether pressure is stable, drifting upwards, or consistently elevated.
Before 50, blood pressure should be checked at minimum every two years if consistently normal, and annually if any reading has been elevated or borderline. A private health check provides an accurate, clinician-reviewed reading in the context of your full clinical picture — not just a number from a pharmacy machine.
Cholesterol and Full Lipid Panel
Elevated cholesterol is one of the most prevalent and most underdiagnosed cardiovascular risk factors in the UK. The British Heart Foundation’s England factsheet confirms that more than half — 53% — of adults in England have cholesterol levels above national guidelines of 5 mmol/L. The majority of them do not know it.
A single total cholesterol reading, while useful as an initial screen, does not tell the full story. A full fasting lipid panel breaks cholesterol down into its clinically meaningful components.
LDL cholesterol (low-density lipoprotein) is the primary driver of atherosclerosis — the build-up of fatty plaques inside arterial walls that narrows blood vessels and increases heart attack and stroke risk. LDL is the number that most directly informs treatment decisions.
HDL cholesterol (high-density lipoprotein) helps remove cholesterol from the arteries and transport it to the liver for disposal. Higher HDL is protective — low HDL is an independent cardiovascular risk factor.
Triglycerides are fats circulating in the blood, elevated by excess sugar, refined carbohydrates, alcohol, and obesity. Raised triglycerides alongside low HDL is a pattern strongly associated with insulin resistance and metabolic syndrome.
NICE cardiovascular risk guidelines confirm that a full formal lipid assessment — not just a total cholesterol reading — should form part of any cardiovascular risk evaluation. For people with a family history of high cholesterol or early heart disease, familial hypercholesterolaemia (FH) should also be considered — a genetic condition causing very high LDL from birth that requires early identification and treatment.
Our private blood tests include a full fasting lipid panel as part of a cardiac-focused blood screen.
Blood Glucose and HbA1c
Diabetes doubles the risk of heart disease and significantly accelerates the development of atherosclerosis. Pre-diabetes — blood glucose levels elevated above normal but not yet in the diabetic range — carries intermediate but meaningful cardiovascular risk and is entirely reversible with lifestyle intervention if identified early.
HbA1c (glycated haemoglobin) is the most reliable screening test for blood glucose status. Rather than measuring glucose at a single point in time, HbA1c reflects average blood glucose over the previous two to three months, making it a far more stable and clinically useful marker than a fasting glucose alone.
A normal HbA1c is below 42 mmol/mol. The pre-diabetic range is 42 to 47 mmol/mol — a window in which dietary changes, weight loss, and increased physical activity can normalise glucose metabolism and prevent progression to type 2 diabetes. Above 48 mmol/mol on two separate tests indicates type 2 diabetes.
HbA1c should be included in any pre-50 cardiac risk assessment, and is particularly important for those who are overweight, physically inactive, have a family history of type 2 diabetes, or are of South Asian, Black African, or Black Caribbean heritage — all of which carry a significantly higher baseline risk for both type 2 diabetes and cardiovascular disease.
Resting ECG
A resting ECG is the only test on this list that provides a direct recording of how the heart is actually functioning in real time. Blood tests measure what is circulating in the bloodstream — an ECG records the heart’s electrical activity, revealing rate, rhythm, and the timing of electrical impulses through the cardiac muscle.
For pre-50 heart health assessment, the most important thing an ECG can detect is atrial fibrillation — an irregular, often rapid heart rhythm in which the upper chambers of the heart beat chaotically rather than in coordinated contractions. Atrial fibrillation is one of the leading causes of stroke in the UK. It is frequently entirely symptom-free, and many people with AF are unaware of it until they are tested or until they have a stroke.
An ECG can also identify other arrhythmias, evidence of a previous silent heart attack, signs of left ventricular hypertrophy (enlargement of the heart’s main pumping chamber — often caused by long-standing high blood pressure), and conduction abnormalities that may warrant further investigation.
An ECG is not part of the standard NHS Health Check — it is not offered routinely until symptoms are present, or unless a specific clinical concern is identified. Getting one privately before 50, as part of a proactive heart health assessment, provides information that no blood test alone can give. Our ECG heart health check-up is available with same-day results reviewed by a GP at our Birmingham clinic.
Additional Tests Worth Considering
Beyond the core five, several additional markers add meaningful information to a pre-50 cardiac risk profile.
CRP (C-reactive protein). CRP is a marker of systemic inflammation — and chronic low-grade inflammation is now well established as an independent cardiovascular risk factor. Elevated high-sensitivity CRP predicts future cardiovascular events beyond what standard lipid and blood pressure measurements capture, and it can be identified and addressed through dietary change, smoking cessation, and treatment of underlying inflammatory conditions. It is included in a comprehensive blood panel and adds useful clinical context alongside the standard lipid screen.
Kidney function. The BHF’s England factsheet confirms that impaired kidney function is associated with 1 in 9 cardiovascular deaths in England. Kidney disease and cardiovascular disease share many of the same risk factors — hypertension, diabetes, and atherosclerosis — and each worsens the other. A routine kidney function panel (creatinine, urea, eGFR) takes seconds to add to a blood draw and can detect early impairment before it is clinically apparent. Our private blood tests include kidney function as standard in a comprehensive cardiac screen.
Waist circumference. Visceral fat — the fat stored around the internal organs rather than under the skin — is metabolically active and a significant driver of insulin resistance, inflammation, and cardiovascular risk. Waist circumference is a more sensitive marker of visceral fat than BMI. For men, a waist above 94cm indicates increased risk; above 102cm, substantially elevated risk. For women, the thresholds are 80cm and 88cm respectively.
Cardiovascular Risk Score
Individual test results are most clinically meaningful when they are combined into a formal risk calculation. The QRISK3 score — the tool used in NHS clinical practice — calculates a ten-year cardiovascular risk percentage by combining blood pressure, cholesterol, age, sex, ethnicity, family history, BMI, smoking status, deprivation, and the presence of several relevant clinical conditions.
NICE guidelines confirm that formal cardiovascular risk assessment using a validated tool is the appropriate basis for treatment decisions — not any single marker in isolation. A person with modestly elevated cholesterol and borderline blood pressure in combination may have a ten-year cardiovascular risk that warrants statin therapy, while someone with the same cholesterol level and normal blood pressure may not. The combined score is what determines clinical action.
Knowing your QRISK3 score before 50 gives you and your GP a clear, evidence-based picture of where you stand and what, if anything, needs to change. Our full health check-up at The Private GP in Birmingham includes all the measurements needed to calculate a formal cardiovascular risk score, with results reviewed and explained by a GP on the same day.
Frequently Asked Questions
At what age should you start having heart health tests?
Blood pressure and cholesterol should be checked from the age of 40 as a minimum, and earlier if you have a family history of heart disease or risk factors such as obesity, smoking, or diabetes. There is no lower age limit for a private health check.
Can you have heart disease before 50 with no symptoms?
Yes. The majority of cardiovascular disease develops silently over years before producing symptoms. Elevated cholesterol, high blood pressure, and pre-diabetes all cause no noticeable symptoms — which is precisely why testing is the only reliable way to detect them.
Is an ECG enough to assess heart health?
An ECG is an important component of heart health assessment, not a standalone screen. It provides unique information about heart rhythm and electrical activity. Combined with blood pressure, lipid panel, HbA1c, and a cardiovascular risk score, it forms part of a complete picture.
What is a good cholesterol level for someone under 50?
Total cholesterol below 5 mmol/L is the general guideline. LDL below 3 mmol/L is desirable; below 2 mmol/L is recommended for those at elevated cardiovascular risk. However, cholesterol thresholds must always be interpreted in the context of your full cardiovascular risk profile, not in isolation.
What should I do if my cardiovascular risk score is high?
Discuss it with your GP at the same appointment. A high QRISK3 score is not a diagnosis — it is a call to action. Depending on the risk level and contributing factors, your GP may recommend lifestyle changes, medication such as statins, or more frequent monitoring. Early intervention at this stage is highly effective.
